Eric Easom
FounderCo-Founder, President & CEO at AN2 Therapeutics
Menlo Park, California, United States
FoundedAN2 Therapeutics
Find your path to Eric
Sign up to see every warm intro you have to Eric
- Paths you didn't know you had: your email and LinkedIn already hold routes to Eric. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Eric Easom is CEO and Co-Founder of AN2 Therapeutics, a biotechnology company focused on infectious diseases. He also serves as a Board Member of the Drugs for Neglected Diseases initiative (DNDi).
Co-Founder, President & CEO at AN2 Therapeutics
Intro paths
In turn, Eric can intro founders to AN2 Therapeutics's investors below.
AN2 Therapeutics's investors · 7
Co-founders at AN2 Therapeutics
Frequently asked questions
- Who is Eric Easom?
- Eric Easom is CEO and Co-Founder of AN2 Therapeutics, a biotechnology company focused on infectious diseases. He also serves as a Board Member of the Drugs for Neglected Diseases initiative (DNDi).
- Where does Eric Easom work?
- Eric Easom is Co-Founder, President & CEO of AN2 Therapeutics.
- What companies did Eric Easom found?
- Eric Easom founded AN2 Therapeutics.
Founder mafias
Indiana University - Kelley School of Business mafia80
Also came through, then founded or led a company.
Eli Lilly mafia73
Also came through, then founded or led a company.
University of Louisville mafia33
Also came through, then founded or led a company.
About this profile. Compiled from public sources — AN2 Therapeutics's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights























